top of page

E2BIO LIFE SCIENCES, LLC

E2Bio Life Sciences is committed to finding solutions for difficult to manage oral mucosal diseases

Home: Welcome

NEWS

large_edited_edited.png

BOCALINER WILL BE AVAILABLE ON THE MARKET IN 2021

October 28, 2020

Bocaliner has now been registered with the Food and Drug Administration as a Class I Medical Device in December 2020. Bocaliner is a proprietary oral device that enhances the medications used to treat patients with chemotherapy and radiation induced oral mucositis.

Bocaliner will be available in 2021 for patients, physicians, hospitals and healthcare distributors.


#bocaliner #e2bio #e2biolifesciences #oralmucositis #chemotherapy #radiationtherapy

Home: News

Subscribe Form

Thanks for submitting!

Home: Subscribe

OUR PRODUCT

A new scientific breakthrough for patients with oral mucositis.

Bocaliner is a new medical device that has been scientifically engineered to help patients that develop oral mucositis while undergoing treatment for cancer. Bocaliner is a soft, lightweight, oral device that is comfortable to wear. Bocaliner is designed for single use and is made from silicone rubber. Bocaliner comes in two sizes for comfortable fitting in the mouth of smaller and larger patients. It works by increasing the time that topical oral therapies stay inside of the mouth.

BOCALINERâ„¢

With Bocaliner in your mouth, your treatment for oral mucositis stays in longer. This can assist the medication to work better.

Bocaliner is a new medical device that has been scientifically engineered to help patients that develop oral mucositis while undergoing treatment for cancer.

​

Bocaliner is a soft, lightweight, oral device that is comfortable to wear. Bocaliner is designed for single use and is made from silicone rubber.

​

Bocaliner comes in two sizes for comfortable fitting in the mouth of smaller and larger patients. It works by increasing the time that topical oral therapies for chemotherapy-induced and radiation-induced oral mucositis. 

Home: Products

MEET OUR TEAM

With a combined 60 years of experience the E2Bio Life Sciences team includes business leaders, clinical researchers and world-renowned medical practitioners. 

Eli Portrait 2_2020.JPG

ELI D. EHRENPREIS, MD

Chief Executive Officer

Eli D. Ehrenpreis is a medical doctor and the Manager of E2Bio Life Sciences. Dr. Ehrenpreis has 30 years of experience as an academic physician, specializing in gastroenterology and clinical pharmacology.

Home: Team

CONTACT US

Our business team will respond back by next business day.

Thanks for submitting!

Home: Contact
bottom of page